The effect of magnesium trisilicate mixture, metoclopramide and ranitidine on gastric pH, volume and serum gastrin.
Eighty women (40 for elective Caesarean section and 40 for elective gynaecological surgery) were randomly assigned to one of five treatment groups and received pre-operatively either no medication; magnesium trisilicate mixture (BP) 30 ml; metoclopramide 10 mg intramuscularly; ranitidine 150 mg orally on the night prior to, and the morning of, surgery; or metoclopramide 10 mg intramuscularly in combination with oral ranitidine 150 mg (the latter again given on the night prior, and the morning, of surgery). The effect of these medications on intragastric pH, volume and serum gastrin-17 was measured. No patient receiving ranitidine had a pH of less than 4. Magnesium trisilicate mixture resulted in the largest intragastric pH change although one woman in this group had a pH of 1.7. The largest intragastric volumes were seen in the patients who had received magnesium trisilicate mixture, whilst the patients who had received metoclopramide in combination with ranitidine had the smallest intragastric volumes. Magnesium trisilicate mixture and metoclopramide resulted in no change in serum gastrin levels. However, in the subjects who had received ranitidine on the night prior to surgery, the fasting serum gastrin was significantly higher (p less than 0.01) than the values in the remaining subjects, the mean (SEM) values being 60.3 (6.3) pg/ml in those not receiving ranitidine and 111.3 (19.5) pg/ml in those who had been given ranitidine.
O'Sullivan
G
G
Sear
J W
JW
Bullingham
R E
RE
Carrie
L E
LE
D000328:Adult; D000863:Antacids / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005755:Gastrins / Q000097:blood; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000627:therapeutic use*; D017633:Magnesium Silicates; D008787:Metoclopramide / Q000627:therapeutic use*; D011015:Pneumonia, Aspiration / Q000517:prevention & control; D011247:Pregnancy; D011292:Premedication; D011899:Ranitidine / Q000627:therapeutic use*; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*; D013270:Stomach / Q000502:physiology*
D000863:Antacids; D005755:Gastrins; D017633:Magnesium Silicates; D012824:Silicic Acid; C013550:gastrin 17; D012822:Silicon Dioxide; D011899:Ranitidine; C001671:magnesium trisilicate; D008274:Magnesium; D008787:Metoclopramide